Fig. 3: Association between digital drug assignment (DDA) and disease control of molecularly targeted agents (MTAs) in the SHIVA01 trial.

Average aggregated evidence level (AEL) score of MTAs in patients with progressive disease and patients achieving disease control (DCR) (stable diseased and partial response).